CRISPR interference directs strand specific spacer acquisition.

PloS One
Daan C SwartsStan J J Brouns

Abstract

CRISPR/Cas is a widespread adaptive immune system in prokaryotes. This system integrates short stretches of DNA derived from invading nucleic acids into genomic CRISPR loci, which function as memory of previously encountered invaders. In Escherichia coli, transcripts of these loci are cleaved into small RNAs and utilized by the Cascade complex to bind invader DNA, which is then likely degraded by Cas3 during CRISPR interference. We describe how a CRISPR-activated E. coli K12 is cured from a high copy number plasmid under non-selective conditions in a CRISPR-mediated way. Cured clones integrated at least one up to five anti-plasmid spacers in genomic CRISPR loci. New spacers are integrated directly downstream of the leader sequence. The spacers are non-randomly selected to target protospacers with an AAG protospacer adjacent motif, which is located directly upstream of the protospacer. A co-occurrence of PAM deviations and CRISPR repeat mutations was observed, indicating that one nucleotide from the PAM is incorporated as the last nucleotide of the repeat during integration of a new spacer. When multiple spacers were integrated in a single clone, all spacer targeted the same strand of the plasmid, implying that CRISPR interferen...Continue Reading

References

Feb 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·S E ConradJ L Campbell
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Dec 11, 2007·Journal of Bacteriology·Philippe HorvathRodolphe Barrangou
Dec 11, 2007·Journal of Bacteriology·Hélène DeveauSylvain Moineau
Aug 16, 2008·Science·Stan J J BrounsJohn van der Oost
Aug 4, 2009·Trends in Biochemical Sciences·John van der OostStan J J Brouns
Jan 9, 2010·Science·Philippe Horvath, Rodolphe Barrangou
Jan 15, 2010·Nature·Luciano A Marraffini, Erik J Sontheimer
Feb 5, 2010·Molecular Cell·Fedor V Karginov, Gregory J Hannon
Feb 6, 2010·Microbiology·C Díez-VillaseñorF J M Mojica
Jun 30, 2010·Cellular and Molecular Life Sciences : CMLS·Melvin Cohn
Jul 6, 2010·Trends in Genetics : TIG·Adi SternRotem Sorek
Jul 14, 2010·Molecular Microbiology·Ksenia PougachKonstantin Severinov
Nov 5, 2010·Nature·Josiane E GarneauSylvain Moineau
Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Matthijs M JoreJohn van der Oost
Apr 5, 2011·Nature Structural & Molecular Biology·Matthijs M JoreStan J J Brouns
May 10, 2011·Nature Reviews. Microbiology·Kira S MakarovaEugene V Koonin
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ekaterina SemenovaKonstantin Severinov
Jun 28, 2011·The Biochemical Journal·Jamieson A L HowardEdward L Bolt
Aug 5, 2011·Nucleic Acids Research·Rimantas SapranauskasVirginijus Siksnys
May 1, 2010·Microbiology·C Díez-VillaseñorF J M Mojica

❮ Previous
Next ❯

Citations

Aug 26, 2014·PloS One·Michael DaumeLennart Randau
Aug 21, 2013·Cellular and Molecular Life Sciences : CMLS·Giedrius GasiunasVirginijus Siksnys
Jun 10, 2014·Nature Reviews. Microbiology·John van der OostBlake Wiedenheft
May 6, 2014·Nature Structural & Molecular Biology·James K NuñezJennifer A Doudna
Feb 7, 2014·Nucleic Acids Research·André PlagensLennart Randau
Mar 8, 2014·Nucleic Acids Research·Ziga ZebecChrista Schleper
Mar 19, 2013·Annual Review of Biochemistry·Rotem SorekBlake Wiedenheft
Apr 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Peter C FineranStan J J Brouns
Mar 19, 2014·Plant Molecular Biology·Liang Liu, Xiu-Duo Fan
Mar 1, 2014·Bioinformatics·Ambarish BiswasChris M Brown
Jul 25, 2014·Nature Communications·Alexander P HynesSylvain Moineau
Aug 12, 2014·BMC Genomics·Anne Kupczok, Jonathan P Bollback
Nov 14, 2012·Annual Review of Genetics·Edze R WestraJohn van der Oost
Apr 15, 2014·Nucleic Acids Research·Sergey ShmakovKonstantin Severinov
Apr 15, 2014·Nucleic Acids Research·Krzysztof ChylinskiEugene V Koonin
Nov 3, 2014·Annual Review of Virology·Ron L DyPeter C Fineran
Dec 25, 2012·BMC Microbiology·Milda PleckaityteAurelija Zvirbliene
Jul 12, 2012·Nature Communications·Kirill A DatsenkoEkaterina Semenova
Feb 7, 2013·Nature Communications·David Paez-EspinoJillian F Banfield
Jul 12, 2016·Current Stem Cell Reports·Simon N WaddingtonHelen C O'Neill
Jan 12, 2016·Nature Reviews. Microbiology·Gil Amitai, Rotem Sorek
Nov 21, 2015·Nucleic Acids Research·Daria VorontsovaEkaterina Semenova
Nov 21, 2015·Nucleic Acids Research·Chaoyou XueDipali G Sashital
Mar 8, 2016·Molecular Cell·Samuel H SternbergUdi Qimron
Mar 10, 2016·BMC Microbiology·Kristina MajsecIvana Ivančić-Baće
Oct 28, 2015·Nature·James K NuñezJennifer A Doudna
Jan 17, 2013·Molecular Microbiology·Ling DengQunxin She
Jul 19, 2012·Molecular Microbiology·Edze R Westra, Stan J J Brouns
Mar 23, 2013·Wiley Interdisciplinary Reviews. RNA·Rodolphe Barrangou
Jan 22, 2013·The EMBO Journal·Tomas SinkunasVirginijus Siksnys
Jan 18, 2014·Molecular Microbiology·Susanne ErdmannRoger A Garrett
May 9, 2014·Molecular Microbiology·Robert HelerDavid Bikard
Oct 10, 2015·Environmental Science and Pollution Research International·Sabine DelannoyPatrick Fach
Mar 11, 2015·Molecular Cell·Timothy R BlosserChirlmin Joo
Oct 4, 2015·Nature·Luciano A Marraffini
Feb 22, 2014·Trends in Genetics : TIG·Rebecca M Terns, Michael P Terns
Apr 15, 2015·Biochimie·Devashish RathMagnus Lundgren

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis

Software Mentioned

house
Cascade

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.